公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2024 | Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer | JIN-YUAN SHIH ; Luo, Yung-Hung; Chang, Gee-Chen; Chang, John Wen-Cheng; Wang, Chin-Chou; Yang, Tsung-Ying; Fang, Wei-Tse; Shau, Wen-Yi | Journal of the Formosan Medical Association = Taiwan yi zhi | | | |
2022 | Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan | Chien, Li-Hsin; Chen, Tzu-Yu; Chen, Chung-Hsing; KUAN-YU CHEN ; Hsiao, Chin-Fu; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Huang, Ming-Shyan; Chen, Yuh-Min; CHIH-YI CHEN ; SHENG-KAI LIANG ; CHUNG-YU CHEN ; Wang, Chih-Liang; Hung, Hsiao-Han; Jiang, Hsin-Fang; Hu, Jia-Wei; Rothman, Nathaniel; Lan, Qing; Liu, Tsang-Wu; Chen, Chien-Jen; PAN-CHYR YANG ; Chang, I-Shou; Hsiung, Chao A | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 1 | 0 | |
2022 | Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP-deficient lung cancer | Chang, Wen-Hsin; Chen, Yi-Ju; Hsiao, Yi-Jing; Chiang, Ching-Cheng; Wang, Chia-Yu; Chang, Ya-Ling; Hong, Qi-Sheng; Lin, Chien-Yu; Lin, Shr-Uen; Chang, Gee-Chen; Chen, Hsuan-Yu; Chen, Yu-Ju; Chen, Ching-Hsien; PAN-CHYR YANG ; SUNG-LIANG YU | EMBO reports | 4 | 5 | |
2021 | The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study | Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO ; YEN-TING LIN ; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 3 | 2 | |
2013 | Risk factors for primary lung cancer among never smokers by gender in a matched case-control study | Lo, Yen-Li; Hsiao, Chin-Fu; Chang, Gee-Chen; Tsai, Ying-Huang; Huang, Ming-Shyan; Su, Wu-Chou; Chen, Yuh-Min; Hsin, Che-Wei; Chang, Chin-Hao; Yang, Pan-Chyr; Chen, Chien-Jen; Hsiung, Chao A. | Cancer Causes Control | | | |
2022 | Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma | Chi-ya Shen; Chang, Wen-Hsin; Chen, Yi-Ju; Weng, Chia-Wei; Regmi, Prabha; Kier, Mickiela K K; KANG-YI SU ; Chang, Gee-Chen; JIN-SHING CHEN ; Chen, Yu-Ju; SUNG-LIANG YU | Journal of proteome research | 4 | 0 | |
2010 | Tumor suppressor HLJ1 switches the double-faced role of nucleophosmin through AP-2α complex formation | Chang, Tzu-Pei; Yu, Sung-Liang; Lin, Sheng-Yi; Hsia, Yi-Jing; Chang, Gee-Chen; Yang, Pan-Chyr; Chen, Jeremy J.W.; 張梓珮; 俞松良; 林聖怡; 蕭乂菁; 張基晟; 楊泮池; 陳健尉 | Cancer Research | | | |
2022 | Various impacts of driver mutations on the PD-L1 expression of NSCLC | Chu, Cheng-Hsiang; Huang, Yen-Hsiang; Lee, Po-Hsin; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen | PloS one | 3 | 1 | |
2023 | Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages | Ho, Hao; SUNG-LIANG YU ; Chen, Hsuan-Yu; Yuan, Shin-Sheng; KANG-YI SU ; Hsu, Yi-Chiung; Hsu, Chung-Ping; Chuang, Cheng-Yen; Chang, Ya-Hsuan; Li, Yu-Cheng; Cheng, Chiou-Ling; Chang, Gee-Chen; PAN-CHYR YANG ; Li, Ker-Chau | Lung cancer (Amsterdam, Netherlands) | 0 | 0 | |